BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy
about
Endoplasmic reticulum stress-mediated pathways to both apoptosis and autophagy: Significance for melanoma treatmentCIViC databaseDifferential chemosensitivity to antifolate drugs between RAS and BRAF melanoma cellsAnalysis of BRAF and NRAS Mutation Status in Advanced Melanoma Patients Treated with Anti-CTLA-4 Antibodies: Association with Overall Survival?SERPINB1 expression is predictive for sensitivity and outcome of cisplatin-based chemotherapy in melanoma.BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival.Prognostic value of pretreatment serum lactate dehydrogenase level in patients with solid tumors: a systematic review and meta-analysis.Coexistence of TERT promoter and BRAF mutations in cutaneous melanoma is associated with more clinicopathological features of aggressiveness.Prognostic relevance of lactate dehydrogenase and serum S100 levels in stage IV melanoma with known BRAF mutation status.BRAF-V600 mutational status affects recurrence patterns of melanoma brain metastasis.
P2860
Q26776032-6AFE6F44-CC50-4A22-AF29-1EC2CF96C0B4Q27612411-E162E7FB-8590-4227-8E42-E9D4A2CF9212Q33838195-065F6834-5EE7-46BC-BAA5-24F803F40EBFQ35794989-3983D91B-E71B-4204-B4C4-19EB899308DDQ36962895-49B2C827-1BB6-493F-AB04-43ED88B936B2Q37174935-05581C3E-3019-4946-8D35-EA1A96840100Q37744341-06CBAD07-DCA9-4B77-92C3-D49752A18D88Q40857012-09C8BEA5-1972-4916-8758-8802B13B9347Q41056748-E16AB538-957A-43E2-8FDE-C6F4B2CBC270Q48656930-C697210F-20A7-403B-97E8-D7F3EDB86D09
P2860
BRAF-V600 mutations have no prognostic impact in stage IV melanoma patients treated with monochemotherapy
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@ast
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@en
BRAF-V600 mutations have no pr ...... treated with monochemotherapy.
@nl
type
label
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@ast
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@en
BRAF-V600 mutations have no pr ...... treated with monochemotherapy.
@nl
altLabel
BRAF-V600 Mutations Have No Pr ...... Treated with Monochemotherapy
@en
prefLabel
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@ast
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@en
BRAF-V600 mutations have no pr ...... treated with monochemotherapy.
@nl
P2093
P2860
P50
P1433
P1476
BRAF-V600 mutations have no pr ...... treated with monochemotherapy
@en
P2093
Annette Pflugfelder
Benjamin Weide
Diana Meckbach
Petra Büttner
Sabina Richter
Ulrike Keim
P2860
P304
P356
10.1371/JOURNAL.PONE.0089218
P407
P577
2014-02-20T00:00:00Z